Plain-English translation of NCT02038127 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study follows patients who are receiving a stent—a small metal tube—to open blocked arteries in the heart. Researchers are comparing three different types of stents: Biomatrix (which releases biolimus A9), Xience (which releases everolimus), and Endeavor Resolute (which releases zotarolimus). The goal is to understand which type works best for different patients over the long term.
When heart arteries become blocked, stents help keep them open. Different stents release different medications to prevent the artery from closing again, but doctors want to know which type offers the best results with the fewest complications for their patients.
You likely qualify if…
You likely don't qualify if…
You will receive one of the three types of stents as part of your heart care during a coronary angiography and intervention procedure. After receiving the treatment, you will be monitored and followed over time—researchers will track how well the stent works, check for any complications, and gather information about your health outcomes. The study involves 5,000 patients being enrolled at sites in Gangwon Province, South Korea.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
South Korea
Sponsor
Yonsei University
Collaborators
Gangwon Cardiovascular Health Research Institute
Enrollment target
~5,000 participants
Started
January 2013
Primary completion
December 2030
Age range
19 Years and older
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Junghan Yoon, M.D., Ph.D.
Yonsei University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.